Search / Trial NCT06234501

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Launched by UNIVERSITY OF READING · Jan 30, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Vitamin B6 Sensory Hyperreactivity Gaba Excitation Inhibition Balance

Description

The main question it aims to answer is: * Does high-dose Vitamin B6 supplementation reduce sensory hyperreactivity differences in autism? * Does high-dose Vitamin B6 supplementation reduce anxiety differences in autism? * Explore the effects of vitamin B6 on sleep quality, Attention Deficit Hyperactivity Disorder (ADHD) scores, and various visual perception tasks that are indicative of GABAergic activity

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Between the ages of 18 to 60
  • * With a diagnosis of autism
  • Exclusion Criteria:
  • * Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
  • * Have a medical history of peripheral neuropathy
  • * lactose intolerance (placebo tablet is lactose based)

About University Of Reading

The University of Reading is a prestigious research institution in the United Kingdom, renowned for its commitment to advancing knowledge across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its cutting-edge research facilities and interdisciplinary expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical research practices and collaboration with industry partners, the University of Reading strives to contribute valuable insights to the field of medicine, fostering the development of new treatments and interventions that address pressing health challenges.

Locations

Reading, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0